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Haematuria, whether macroscopic (visible) or microscopic (non-
visible), is one of the most common reasons for referral to a urologist. [1] 
It is estimated to account for one-fifth of all urological visits and for 
a significant proportion of all urological hospitalisations. [2] This 
common symptom has a multitude of differential diagnoses, broadly 
classified into urological and nephrological causes.
Urological causes range from benign conditions such as idiopathic 
microscopic haematuria to advanced genitourinary malignancies. 
Evidence shows that as many as 24% of patients with haematuria are 
diagnosed with bladder, upper urinary tract and renal tumours, and 
up to 53% of those initially considered to have benign conditions are 
found to have genitourinary malignancies.[2-4] It is therefore vital that 
evaluation of haematuria is initiated as soon as possible to avoid the 
morbidity and mortality associated with a delayed diagnosis.
Bladder cancer ranks in the top 10 most prevalent histologically 
diagnosed cancers in South Africa (SA). It carries a varying estimated 
lifetime risk in the population, with factors such as gender and race 
contributing significantly to the risk of developing the malignancy. 
In SA, individuals self-identifying as white and coloured males had 
the highest risk profile, with an estimated life-risk of 1:60 and 1:76, 
respectively, of developing the disease (CANSA Fact Sheet, 2014[5]). 
Smoking remains the behavioural factor most strongly associated 
with the development of urothelial cancers.[6]
It is known that bladder transitional cell carcinoma (TCC) can 
progress to muscle invasion in a relatively short period of time, and 
it is therefore of critical importance that screening and diagnostic 
services are made as accessible as possible to communities at risk 
to capture urothelial malignancies early in their development.[7] 
In settings where such facilities have been established for a while, 
the rate of diagnosis of TCC is higher than in places without 
them, enabling early initiation of treatment and therefore markedly 
improving patient prognosis.[8,9]
Objectives
The one-stop haematuria clinic (OSHC) at Groote Schuur Hospital 
(GSH) in Cape Town, SA, was established in 2008 with the goal of 
ensuring rapid and complete assessment by a consultant urologist at 
a single hospital visit. The objectives of this study were to provide an 
overall audit of the feasibility and practicality of this approach and to 
report on the collected outcomes of patients seen at the OSHC over 
a 3.5-year period.
Methods
Patient selection
A retrospective assessment of folders for patients reporting to the 
weekly GSH OSHC for the period January 2012 - October 2015 was 
conducted following ethical approval from the Faculty of Health 
Sciences Human Research Ethics Committee at the University of 
Cape Town (ref. no. 868/2015). The clinic is open for 3 hours every 
Monday afternoon, from an outpatient setting, and the consultant 
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sees between three and five patients 
a week. Patients are referred to the clinic 
by general practitioners and primary and 
secondary public hospitals, and there is also 
interdepartmental referral within GSH. Data 
collection was done by SS (first author), JJ, GP, 
SS and JL. The presence of visible haema turia 
at the time of the visit qualified a patient for 
inclusion into the study, while patients with 
microscopic haematuria and those reporting 
for follow-up visits were excluded.
Procedure
Every patient visiting the clinic was seen by 
a consultant urologist, and the consultation 
started with a focused history. Emphasis 
was placed on identifying risk factors for 
urothelial malignancies, including but not 
limited to age >50 years, a family history of 
urological malignancies, a history of smoking, 
and exposure to occupational urothelial 
carcinogens. After a focused physical 
examin ation, urinalysis was performed to 
exclude any ongoing urinary tract infection 
and to identify proteinuria, which would 
suggest a possible nephrological cause of 
haematuria. A kidney-ureter-bladder (KUB) 
ultrasound scan was then performed. An 
explanation of planned investigations was 
given and consent was obtained from the 
patient, followed by flexible cystoscopy 
under local anaesthesia.
If no significant pathology and no 
identifiable risk factors were observed, 
patients were reassessed within a year 
of their initial visit at the GSH urology 
outpatient clinic. Those classified as 
negative for haematuria at this follow-up 
visit were advised to return in the event 
of any recurrence of symptoms. Patients 
with a suspected nephrological cause of 
macroscopic haematuria were referred to 
the renal unit. Those requiring further 
investigations (urine cytology, computed 
tomography/magnetic resonance imaging, 
urography) were followed up in the urology 
outpatient clinic. Finally, patients with 
identifiable pathology and needing further 
intervention (transrectal ultrasound biopsy 
of the prostate, transurethral resection of 
bladder tumour, radical nephrectomy or 
stone surgery) were counselled and placed 
on the waiting list.
Statistical analysis
Explorative univariate statistical analysis 
of the extracted data was done. Statistical 
inferences on binary sets of data were 
performed using Fisher’s exact test. Statistical 
analyses were performed using GraphPad 
Prism version 5.0 for Windows (GraphPad 
Software, USA). All tests were two-tailed and 
p-values <0.05 were considered significant.
Results
A total of 477 patients referred to the OHSC 
at GSH were reviewed for inclusion into the 
study. Of these, 26 were classified as having 
microscopic haematuria, and a further 174 
were identified as follow-up patients and 
were excluded. Two further participants with 
missing records for essential end-points for 
the study were also excluded. A final set 
of 275 patients were retrospectively inclu-
ded into the study, with a median age of 
60  years (interquartile range 49 - 69). Ages 
were similar for the 198 men (72.0%) and 
77 women (28.0%); most patients were aged 
>50 years (73.1%), with the 60 - 69-year age 
group being the most populated category 
(29.5%) (Fig. 1A). A significant majority 
(75.6%) of participants in the study self-
identified as coloured when asked about 
their ethnicity, and more than half of 
the study group classified themselves as 
coloured males (54.2%) (Fig. 1B).
Diagnostic outcomes
Of the patients undergoing work-up for 
macroscopic haematuria (urine dipstick, 
cytology, full blood count, creatinine-
electrolyte-urea, KUB ultrasound scan, 
flexible cystoscopy), the cause of haematuria 
was established in 22.2% and in the 
remaining 77.8% no cause was detected after 
initial investigations (Fig. 2A). Nine patients 
(3.3%) were diagnosed as having kidney 
stones, and 55 (20.0%) were discovered to 
have malignant lesions requiring surgery 
and were put on a waiting list (Fig. 2A). 
Eighty percent of cancers were detected in 
men (Fig. 2B), and a basic breakdown of 
these malignancies revealed that most were 
bladder cancers (86.8%), a smaller portion 
being renal cell carcinomas (11.6%) and 
upper tract TCCs (1.6%) (Fig. 2A). Fig. 3A 
shows the further breakdown of urological 
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Fig. 1. Patient age distribution (A) and self-identified ethnic distribution (B), by gender.
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Fig. 2. Percentage breakdown of diagnoses for included cases (A) and incidence of cancers in included 
cases (B). (TCC = transitional cell carcinoma.)
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Fig. 3. Distribution of cancers across age (A) and self-identified ethnicity, by gender (B).
852       November 2019, Vol. 109, No. 11
RESEARCH
cancers for the various age groups, with 
58.2% of cancers detected in patients in 
the 50 - 69-year group and coloured males 
making up the majority of detected cancer 
cases (67.5%) (Fig. 3B).
Staging and grading
Of the 55 cancer cases, 51 were classified 
as TCC and 2 each as adenocarcinoma 
and squamous cell carcinoma (Fig. 4A). 
Staging of the TCC cases revealed that 46 
of them classified as localised (carcinoma 
in situ (CIS), Ta, T1 and T2) and 5 as locally 
advanced cancers (T3 and T4) (Fig. 4B). 
Finally, TCC high grade (HG) represented 
the most commonly identified cancer in this 
study (43.2%, Fig. 4C). No concurrent CIS 
was identified. No relevant pattern of interest 
was observed when looking at grading and 
staging of cases across the ethnic groups 
(data not shown).
Discussion
OSHCs have been in existence for more than 
three decades globally.[10] With the intention 
of moving away from the traditional format 
where diagnostic tests are typically ordered 
at the first visit to the urologist and a follow-
up appointment is required to assess the 
results, the aim of an OSHC is to provide a 
streamlined and rapid investigative service 
for all patients presenting with haematuria in 
an effort to decrease morbidity and mortality 
by earlier diagnosis of urological malignancy. 
Evidence shows that early diagnosis 
considerably improves the 1-year survival 
rate for bladder and renal malignancies, 
and that this can be as high as 92 - 97%. 
However, if patients are diagnosed late, the 
rate decreases significantly to 25 - 34%.[11] It 
is therefore important to make the diagnosis 
as soon as possible and initiate treatment 
without delay. This is not always achievable 
in an overburdened public healthcare 
system, where delays in initiating treatment 
represent the main factor contributing to 
cancer morbidity and mortality. The present 
study excluded patients with invisible 
haematuria and those who were attending 
for follow-up visits. A recent prospective 
analysis confirmed that patients with dipstick 
haematuria and negative investigations 
are extremely unlikely to have significant 
urological disease.[4] It must be stated that 
although priority is given at our OSHC to 
patients with visible haematuria, patients 
with microscopic haematuria are still worked 
up according to international guidelines in 
the urology outpatient department.
In the majority of patients (77.8%), 
the cause of the macroscopic haematuria 
was indeterminate and transient, and 
resolved without treatment. Where a 
cause was identified, malignancies of the 
upper genitourinary tract, kidney and 
bladder were responsible for most of the 
macroscopic haematuria. In line with 
previous reports,[4,12,13] a relatively small 
fraction (3.3%) of patients in our study 
were diagnosed with kidney stones. Other 
common conditions such as urinary tract 
infection and benign prostate hyperplasia 
have not been described individually here, 
as we believe that they accounted for the 
majority of the indeterminate group in 
this study. Bladder cancer alone accounted 
for 16.4% of macroscopic haematuria. 
According to incidence reports from 
the 2014 South African National Cancer 
Registry,[5] bladder cancer remains among 
the top 10 cancers diagnosed in South 
Africans. The ethnic and gender links to 
bladder cancer incidence found in the 
present study cannot be generalised to 
a nationwide context, mainly because of 
the completely different demographic in 
the study setting relative to the rest of the 
country. More than three-quarters of the 
patients with bladder cancer in this study 
were diagnosed in the early stages of the 
malignancy (Ta and T1). Fifty percent of 
participants were histologically diagnosed 
with more aggressive malignancies (TCC 
HG and CIS). Detecting bladder cancer by 
ultrasound and flexible cystoscopy results in 
expedited, definitive and curative treatment, 
where possible. Patients with bladder cancer 
referred within 2 weeks of the onset of their 
symptoms have been shown to have a 5% 
survival advantage over those with more 
delayed referral.[12] In addition, patients with 
metastatic disease can be referred to pallia-
tive care colleagues almost immediately.
Initially, it can be a challenge to get an 
OSHC up and running. However, with a 
dedicated team of nurse practitioners assis-
ting the consultant urologist, the advantages 
to the patient, the urologist and the hospital 
are many. Patients require fewer appointments 
before a diagnosis is made, they can build a 
relationship with a single urologist, and 
they can avoid additional anxiety related 
to a delay in establishing a diagnosis.[13-15] 
In addition, for hospitals like GSH that 
service a large rural population, the OSHC 
is even more relevant. The financial burden 
of repeated visits can be reduced. One-stop 
clinic patients are more likely to return for 
care and to recommend this service, both of 
which are indicators of patient satisfaction. 
The hospital can service more patients more 
effectively and reduce the cost of repeated 
and often unnecessary visits.
From this retrospective series of haema-
turia cases, it is worth pointing out that fewer 
than one-third of all the patients included in 
the study qualified for referral to GSH for 
screening based on their geographical status, 
and the remaining patients should have been 
cared for at healthcare facilities draining 
their area (Fig. 5). The biggest drainage area 
that was serviced at the GSH OSHC was the 
Cape Flats, where almost half of the patients 
enrolled should have reported to the closest 
medical facilities (Fig. 5: Mitchell’s Plain 
District Hospital 37.8%, Khayelitsha District 
Hospital 11.5%) for screening in the early 
stages of their symptoms if the service had 
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been available there. Of all cancer cases 
identified in this study, 80% could have 
been screened earlier at their respective 
healthcare facilities had there been a regular 
OSHC there, and referred for the appropriate 
standard of care at a designated tertiary 
centre.
Conclusions
The OSHC was designed to be an efficient 
diagnostic unit where patients undergo 
tests that confirm the presence or absence 
of malignancy, thus potentially decreasing 
periods of delay between diagnosis and 
treatment. The fact that three-quarters of 
the cancer diagnoses made in this study 
were in the early stages is a good reflection 
of the efficacy of this specialised clinic. 
It has fast-tracked the management of all 
patients (both early and late diagnoses), 
leading to a reduction in morbidity and 
mortality, and we recommend that similar 
clinics be implemented in areas of high 
risk to adequately attend to the needs of 
patients in these communities. In addition, 
with the much anticipated and criticised yet 
inevitable National Health Insurance on the 
horizon, general practitioners will be put 
‘back at the centre’ of patient care.[16] OSHCs 
need not be limited to tertiary centres with 
specialist urology services. Specially trained 
general practitioners serving the community 
can be empowered to establish such clinics, 
only referring patients who need specialist 
urology services. We encourage more health 
centres in SA to establish such units to 
optimise patient service delivery.
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Fig. 5. Geographical coverage of referrals to the GSH one-stop haematuria clinic, with the closed black 
circles (●) on the map of the Cape Town metropole representing the proportions of patients coming from 
these respective areas (size determined by proportion). The six secondary and tertiary medical facilities 
(GSH = Groote Schuur Hospital; KDH = Khayelitsha District Hospital; MPDH = Mitchell’s Plain 
District Hospital; NSH = New Somerset Hospital; TH = Tygerberg Hospital; VH = Victoria Hospital) 
covering the metropole are included in the map to provide a sense of proximity to patients’ dwellings. An 
indication of potential redistribution of referrals to centres closest to patients’ dwellings is also provided, 
with the size of the coloured circles next to the facility names denoting the proportions of referrals that 
could be redirected to each facility if it was upgraded for haematuria screening.
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